Status:
COMPLETED
Neuropsychiatric Scleroderma Study: Systematic Evaluation of Neuropsychiatric Involvement in Systemic Sclerosis
Lead Sponsor:
University Hospital, Lille
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Systemic sclerosis is a rare disease with vascular involvement and systemic fibrosis. This disease is usually thought to spare central nervous system. However, neuropsychiatric manifestations like dep...
Eligibility Criteria
Inclusion
- Male or female between 18 and 65 yo
- With scleroderma (American College of Rheumatology and/or Leroy et Medsger)
- Informed consent given
Exclusion
- Other auto-immune disease
- non french native speakers
- severe arterial hypertension
- diabetes
- anemia
- renal insufficiency
- cranial trauma
- history of neurological disorder or neurotoxic treatment
- pregnancy or breast feeding
- impossibility or non compliance to perform the protocol flow chart
- contra indications to MRI
Key Trial Info
Start Date :
February 16 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 24 2017
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT01488214
Start Date
February 16 2011
End Date
October 24 2017
Last Update
November 9 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Caen University Hospital
Caen, Calvados, France, 14000
2
Lille University hosiptal
Lille, Nord, France, 59000
3
Rouen University hospital
Rouen, Seine-Maritime, France, 76 000
4
Amiens Launay
Amiens, Sommes, France, 80 000